Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05441644
Other study ID # USM/JEPeM/20060307
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date June 30, 2020
Est. completion date May 30, 2022

Study information

Verified date June 2022
Source Universiti Sains Malaysia
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

A study to find agreement of the infraorbtal BIS placement as compared to standard frotal placement


Description:

2.1 Study Design This was a prospective, cross-sectional study conducted in single centre, University Hospital. The study protocol was reviewed and granted approval for implementation by the institution Human Research and Ethics Committee (study protocol code: USM/JEPeM/20060307). 2.2 Study Population We recruited 71 patients who were eligible to be enrolled in this study from November 2020 to October 2021. The inclusion criteria were consented adults between the age of 18 and 60 years old, BMI > 18 and <30 kg/m2 and ASA physical status I or II underwent general elective surgery under general anaesthesia. We excluded patients who were going for neurosurgery, maxillofacial or facial surgical procedures because the operation site may interfere with the BIS sensors placement. Patients with a history of disabling central nervous or cerebrovascular disease, those on psychiatric medication or central nervous system active drugs, and those who had undergone neurosurgical procedure were also excluded. The patient who had interruption of BIS monitoring of any BIS sensor location at any time frame will be withdrawn from the study. The baseline demographic data of patients were extracted from their medical chart. Demographic data include their age, gender, BMI, ASA physical status and type of surgery. 2.3 Study Method Before induction of anaesthesia, we applied two BIS sensors on each patient at different location (frontal & infra-orbital) and connected two different BIS monitor. Frontal sensors were applied with circle 1 at the centre of forehead, circle 2 2.8cm lateral to circle 1, circle 3 on the corner of the eye and circle 4 in between circle 2 and circle 3 (Picture 1(A)). Infra-orbital sensors were applied with circle 1 across the nose bridge, circle 2 adjacent to circle 1, circle 3 medial from the frontally placed third electrode and circle 4 in between circle 2 and 3 (Picture 1 (B)). Anaesthesia was induced with TCI remifentanil at initial target concentration at 2ng/ml up to 4ng/ml followed with TCI propofol at initial target concentration at 4mcg/ml then titrated upwards to loss of consciousness and intravenous (IV) rocuronium 1.0 mg/kg for muscle relaxant and endotracheal intubation. Anaesthesia was maintained with propofol infusion at target plasma concentration of 3-6mcg/ml and remifentanil 1-8ng/ml; Intra-operative analgesia included IV paracetamol 1g, IV parecoxib 40mg and IV morphine 0.05-0.1mg/kg. At the end of surgery, patients were reversed with IV neostigmine 0.05 mg/kg and atropine 0.02mg/kg. BIS values from each BIS monitor during awake, at loss of consciousness (LOC), after intubation, after the start of surgical incision, every 30 minutes during the intraoperative period (maintenance), after cessation of TCI propofol at which the plasma concentration of propofol is 1.5mcg/ml (emergence) and at extubation were recorded. The frontal BIS was used to guide the depth of anaesthesia, with deep (BIS < 45), moderate (BIS 45 to 60) and mild hypnosis (BIS >60). 2.4 Sample Size In order to determine the Kappa agreement for Pearson's correlation between BIS values obtained from frontal versus the infra-orbital sensor position, using t-test, the sample size would be determined with parameter of effect 0.3, an alpha of 0.05 and a power of 80%. The sample size required was 64 patients and with the estimation of 10% drop-out rate, the total number would be 71 patients. In order to determine the relationship between BIS values obtained from frontal versus the infra-orbital sensor position, using linear regression, the sample size would be determined with parameter of effect size 0.15, an alpha of 0.05 and a power of 80%. The sample size required was 55 patients. To satisfy both outcomes, the final sample size for this study would be 71 patients. 2.5 Statistical Analysis Data were recorded and analyzed using SPSS for Window version 22.0. Descriptive statistics were used to summarize the socio-demographic characteristics of subjects. Numerical data were presented as mean (SD) or median (IQR) based on their normality distribution. Categorical data were presented as number and percentage. Correlation of the numerical data obtained from the two different groups were analyzed using Pearson's correlation and scatter plot analysis. Relationship between data obtained from the two groups was determined using simple linear regression.


Recruitment information / eligibility

Status Completed
Enrollment 71
Est. completion date May 30, 2022
Est. primary completion date December 31, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 60 Years
Eligibility The inclusion criteria were consented adults between the age of 18 and 60 years old, BMI > 18 and <30 kg/m2 and ASA physical status I or II underwent general elective surgery under general anaesthesia. We excluded patients who were going for neurosurgery, maxillofacial or facial surgical procedures because the operation site may interfere with the BIS sensors placement. Patients with a history of disabling central nervous or cerebrovascular disease, those on psychiatric medication or central nervous system active drugs, and those who had undergone neurosurgical procedure were also excluded. The patient who had interruption of BIS monitoring of any BIS sensor location at any time frame will be withdrawn from the study.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Bispectral index
A new placemewnt to monitor intraoperative BIS

Locations

Country Name City State
Malaysia School Of Medical Sciences, Health Campus, Universioti Sains Malaysia Kubang Kerian Kelantan

Sponsors (1)

Lead Sponsor Collaborator
Universiti Sains Malaysia

Country where clinical trial is conducted

Malaysia, 

Outcome

Type Measure Description Time frame Safety issue
Primary agreement between frontal BIS vs infraorbital BIS measurements of BIS values on both placement intraoperative
Secondary correlation between frontal BIS vs infraorbital BIS to find correlation between both measurement intraoperative
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05250882 - Enhanced Perioperative Care for the Prevention of Colorectal Anastomotic Leakage N/A
Completed NCT01868178 - Relationship Between Bispectral Index (BIS) and Spectral Entropy (SpEn) During Desflurane Anaesthesia N/A
Completed NCT01800578 - Awareness During Blended Anaesthesia N/A
Suspended NCT03571945 - Incidence of Intraoperative Awareness in Indian Patient Population N/A
Not yet recruiting NCT04086940 - Role of Intraoperative Beta Blocker for Morbid Obese Patients Undergoing Laparoscopic Bariatric Surgery Phase 4
Completed NCT02583295 - The Impact of Maternal Sound on Awareness for Pediatric Patients Undergoing Cardiac Surgery N/A
Recruiting NCT05857618 - Study to Determine if Patients Exposed to General Anesthesia Significant Numbers of Times Would Increase the Risk for Intraoperative Awareness.
Completed NCT01600287 - Closed Loop Propofol Administration in Pediatric Cardiac Surgery N/A
Recruiting NCT04252911 - Standard Vs Supralabial Bispectral Index Scores
Completed NCT03209323 - Epileptiform EEG Patterns During Induction of General Anaesthesia With Sevoflurane Compared to Those With Propofol N/A
Completed NCT05385146 - Effect of Chan-Chuang Qigong With Breathing Meditation on Quality of Life in Patients With Breast Cancer N/A
Completed NCT03508102 - Effect of Remifentanil on the Bispectral Index in Women Undergoing Caesarean Delivery Under General Anaesthesia N/A
Completed NCT01377636 - Measurement of Bispectral Index and Awareness in Patients Undergoing Electrophysiology Studies With Isoproterenol N/A